HLA class II DRB1, DQB11, DPB1 polymorphism and cardiomyopathy due to Trypanosoma cruzi chronic infection

Human Immunology

Volumn 61, Issue 3, 2000, Pages 320-325

  Colorado, Iriana Alexandria ^a   Acquatella, Harry ^a   Catalioti, Franco ^a   Fernandez, Mercedes Teresita ^a   Layrisse, Zulay ^a  

^a INSTITUTO VENEZOLANO DE INVESTIGACIONES CIENTÍFICAS   (Venezuela)

Author keywords

Cardiomyopathy; Chagas disease; DP; DR; HLA; Polymorphism; T. cruzi

Indexed keywords

HLA ANTIGEN CLASS 2; HLA DP ANTIGEN; HLA DR ANTIGEN;

ALLELE; ARTICLE; CARDIOMYOPATHY; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; GENETIC POLYMORPHISM; HEART ARRHYTHMIA; HUMAN; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SOUTH AND CENTRAL AMERICA; TRYPANOSOMA CRUZI; TRYPANOSOMIASIS;

AMINO ACID SEQUENCE; ANIMALS; CHAGAS CARDIOMYOPATHY; GENE FREQUENCY; GENES, MHC CLASS II; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HLA-DP ANTIGENS; HLA-DQ ANTIGENS; HLA-DR ANTIGENS; HUMANS; MOLECULAR SEQUENCE DATA; POLYMORPHISM, GENETIC; SEQUENCE HOMOLOGY, AMINO ACID; VENEZUELA;

EID: 0033999353     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0198-8859(99)00177-9     Document Type: Article

References (28)

1. Hagar J.M., Rahimtoola S.H. Chagas' heart disease. Curr Probl Cardiol. 20:1995;825.
2. Control of Chagas' disease. Report of a WHO expert committee. WHO Rep Tech Ser 811:1, 1991.
3. Cunha-Neto E., Duranti M., Gruber A., Zingales B., DeMessias I., Stolf N., Bellotti G., Patarroyo M.E., Pilleggi F., Kalil J. Autoimmunity in Chagas disease cardiophathy biological relevance of a cardiac myosin-specific epitope crossreactive to an immunodominant Trypanosoma cruzi antigen. Proc Natl Acad Sci USA. 92:1995;3541.
4. Kalil J., Cunha-Neto E. Autoimmunity in Chagas disease cardiomyopathy fulfilling the criteria at last? Parasitol Today. 12:1997;396.
5. Acquatella H., Catalioti F., Gomez J.R., Piccone-Oseroff C., Layrisse Z. Asociación entre HLA-DB9 y enfermedad de Chagas. Rodriguez-Lemoine V. Genética VI Congreso Latinoamericano de Genética. 1984;328 Ars. Gráfica S.A, Maracaibo, Venezuela.
6. Llop E., Rothhammer F., Acuña M., Apt W. HLA antigens in cardiomyopathic Chilean Chagasics. Am J Hum Genet. 43:1988;770.
7. Fernandez M.T., Layrisse Z., Montagnani S., Acquatella H., Catalioti F., Matos M., Balbas O., Makhatadze N., Dominguez E., Herrera F., Madrigal A. Influence of the HLA Class II polymorphism in chronic Chagas' disease. Parasite Immunol. 20:1998;197.
8. Eckels D.D., Lake P., Lamb J.R., Johnson A.W., Shaw S., Woody J.N., Hartzman R.J. SB-restricted presentation of influenza and herpes simplex virus antigens to human T-lymphocyte clones. Nature. 301:1983;716.
9. Austin P., Trowsdale J., Rudd C., Bodmer W., Feldman M., Lamb J. Functional expression of HLA-DP genes transfected into mouse fibroblast. Nature. 313:1985;61.
10. De Koster H.S., Anderson D.C., Termijtelen A.M. T cells sensitized to synthetic HLA/DR3 peptide give evidence of continuous presentation of denatured HLA-DR3 molecules by HLA-DP. J Exp Med. 169:1989;1191.
11. Oza A., Tonks S., Lim J., Fleetwood M.A., Lister T.A., Bodmer J.G. A clinical and epidemiological study of human leukocyte antigen DPB alleles in Hodgkin's disease. Cancer Res. 54:1992;5101.
12. Taylor G.M., Cokhale D.A., Crowther D. Increased frequency of HLA-DPB1*0301 in Hodgkin's disease suggest that susceptibility is HVR-sequence and subtype-associated. Leukemia. 10:1996;854.
13. Begovich A.B., Bugawan T.L., Nepom B.S., Klitz W., Nepom G.T., Erlich H.A. A specific HLA-DP beta allele is associated with pauciarticular juvenile rheumatoid arthritis but not adult rheumatoid arthritis. Proc Natl Acad Sci USA. 86:1989;9489.
14. Paul C., Yao Z., Nevinny-Stickel C., Keller E., Schoenwald U., Truckenbordt H., Hoza J., Suschke H.J., Albert E.D. Immunogenetics of juvenile chronic arthritis. Tissue Antigens. 45:1995;280.
15. Dong R.P., Kimura A., Okubo R., Shinagawa H., Tamai H., Nishimura Y., Sasazuki T. HLA-A and DPB1 loci confer susceptibility to Grave's disease. Hum Immunol. 35:1992;165.
16. Erlich H.A., Rotter J.I., Chang J.D., Shaw S.J., Raffel L.J., Klitz W., Bugawan T.L., Zeidleer A. Association of HLA-DPB1*0301 with IDDM in Mexican-Americans. Diabetes. 45:1996;610.
17. Acquatella H., Catalioti F., Gomez-Mancebo J.R., Davalos V., Villalobos L. Long-term control of Chagas disease in Venezuela effects on serologic findings, electrocardiographic abnormalities, and clinical outcome. Circulation. 76:1987;556.
18. Bignon J.D., Fernandez-Viña M.A., Cheneau M.L., Fauchet R., Schreuder GMTh, Clayton J., Marsh S.G.E., Charron D. HLA DNA class II typing by PCR-SSOP 12th International Histocompatibility Workshop experience. Charron D. Genetic Diversity of HLA. Functional and Medical Implication. Vol I:1997;21 EDK, Paris.
19. Clayton J.F., Lonjou C., Marsh S.G.E., de Lange P., Schreuder GMTh, Fauchet R., Raffoux C. The data capture package. Charron D. Genetic Diversity of HLA. Functional and Medical Implication. Vol I:1997;475 EDK, Paris.
20. Schneider S., Kueffer J.M., Roessli D., Excoffer L. Arlequin Version 1.1 A Software For Population Genetic Data Analysis. 1997;Genetics and Biometry Laboratory, University of Geneva, Geneva, Switzerland.
21. Woolf B. On estimating the relation between blood group and disease. Ann Hum Genet. 19:1955;251.
22. Haldane J.B.S. The estimation and significance of the logarithm of a ratio of frequencies. Ann Hum Genet. 20:1956;309.
23. Bugawan T.L., Begovich A.B., Erlich H.A. Rapid HLA-DPB typing using enzymatically amplified DNA and nonradiactive sequence-specific oligonucleotide probes. Immunogenetics. 32:1990;231.
24. de Koster H.S., Kenter M.J.H., D'Amaro J., Luiten R.M., Schroeijers W.E.M., Giphart M.J., Termijtelen A. Positive correlation between oligonucleotide typing and T-cell recognition of HLA-DP molecules. Immunogenetics. 34:1991;12.
25. Richeldi L., Sorrentini R., Saltini C. HLA DPB1 glutamate 69 a genetic marker of beryllium disease. Science. 262:1993;242.
26. Lympany P.A., Petrek M., Southcott A.M., Tatlor A.J.N., Welsh K.I., Du Bois R.M. HLA-DPB polymorphism Glu 69 association with sarcoidosis. Eur J Immunogenet. 23:1996;353.
27. Meyer C.G., Schnittger L., May J. Met-11 of HLA Class II DP alfa 1 first domain associated with onchocerciasis. Exp Clin Immunogenet. 13:1996;12.
28. Gilchrist F.C., Bunce M., Lympany P.A., Welsh K.I., du Bois R.M. Comprehensive HLA-DP typing using polymerase chain reaction with sequence-specific primers and 95 sequence-specific primer mixes. Tissue Antigens. 51:1998;51.